tiprankstipranks
Trending News
More News >

Adherium Announces Investor Webinar on Retail Entitlement Offer

Story Highlights
  • Adherium Limited will host a webinar to update on its Retail Entitlement Offer.
  • The offer is open to eligible shareholders in Australia and New Zealand until July 10, 2025.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Adherium Announces Investor Webinar on Retail Entitlement Offer

Elevate Your Investing Strategy:

An announcement from Adherium Ltd. ( (AU:ADR) ) is now available.

Adherium Limited has announced an Investor Webinar to update the market on its Retail Entitlement Offer, which is open to eligible retail shareholders in Australia and New Zealand. The offer began on July 1, 2025, and will close on July 10, 2025. The webinar, scheduled for July 9, 2025, will feature a presentation by Non-Executive Director Kevin Gessner, providing important updates for shareholders and supporters. This initiative is part of Adherium’s ongoing efforts to engage with its stakeholders and provide transparency regarding its financial strategies.

More about Adherium Ltd.

Adherium is a leading provider of integrated digital health solutions and a global leader in connected respiratory medical devices, having sold over 180,000 units worldwide. The company’s Hailie® platform offers tools for clinicians, healthcare providers, and patients to monitor medication usage and adherence remotely, supporting patient management reimbursement. The platform includes mobile and desktop apps, SDK and API integration tools, and a range of sensors connected to respiratory medications, aiding healthcare providers in understanding patient respiratory disease patterns.

Technical Sentiment Signal: Sell

Current Market Cap: A$8.98M

Learn more about ADR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1